Search Within

Allison Gordon

Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
  3. Research Letter (4)
  4. Correspondence (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (17)
  2. Dermatology (17)
  3. Dermatology Service (17)
  4. Division of Subspecialty Medicine (17)
  5. Survivorship Research (11)
  6. Melanoma Disease Management Team (10)

More Groups

People
  1. Alina Markova (8)
  2. Mario Lacouture (5)
  3. Veronica Rotemberg (5)
  4. Gopakumar Iyer (4)
  5. Andrea Moy (3)
  6. Anthony Rossi (3)

More People

Years
  1. 2025 (5)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (2)
Publications
  1. Journal of the American Academy of Dermatology (4)
  2. Journal of Clinical Oncology (3)
  3. JAAD Case Reports (2)
  4. American Journal of Clinical Dermatology (1)
  5. Cancer Medicine (1)
  6. JAMA Dermatology (1)

More Publications

Publishers
  1. Mosby Elsevier (4)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (2)
  4. Adis International Ltd (1)
  5. American Medical Association (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Research Letter

    Kuo, A. M.; Hassoun, H.; Shah, U.; Gordon, A.; Hollmann, T. J.; Landau, H. J.; Lezcano, C.; Mailankody, S.; Tan, C. C.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Oncodermatology: Advancing the science and care of cancer patients and survivors
    Research Letter

    Bang, A. S.; Anadkat, M. J.; Choi, J. N.; LeBoeuf, N. R.; Jung, J. Y.; Markova, A.; Gordon, A.; Rossi, A. M.; Noor, S. J.; Sibaud, V.; more...
    American Journal of Clinical Dermatology (2022)

    Fulltext@MSK | Save
  • Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes
    Meeting Abstract

    Gu, L.; Paras, M.; Rao, D.; Rotemberg, V.; Capanu, M.; Chou, J. F.; Sigel, C. S.; Busam, K. J.; Boyce, L.; Gordon, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Hepcidin levels can distinguish anemia of chronic disease from iron deficiency anemia in a cross-sectional study of patients with hidradenitis suppurativa
    Research Letter

    Ghias, M. H.; Johnston, A. D.; Babbush, K. M.; Kutner, A. J.; Hosgood, H. D.; Lowes, M. A.; Gil, M. R.; Cohen, S. R.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Supporting virtual dermatology consultation in the setting of COVID-19
    Journal Article

    Kutner, A.; Love, D.; Markova, A.; Rossi, A.; Lee, E.; Nehal, K.; Lacouture, M.; Rotemberg, V.
    Journal of Digital Imaging (2021)

    Fulltext@MSK | Save
  • Authors' reply to the comment “High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa”
    Correspondence

    Ghias, M. H.; Johnston, A. D.; Kutner, A. J.; Micheletti, R. G.; Hosgood, H. D.; Cohen, S. R.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save